Published in Vaccine on February 01, 1998
Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol (2006) 1.51
Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial. PLoS One (2015) 1.46
Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol (2005) 1.15
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics (2010) 1.00
History of vaccination. Proc Natl Acad Sci U S A (2014) 0.98
Cell-line-induced mutation of the rotavirus genome alters expression of an IRF3-interacting protein. EMBO J (2004) 0.93
Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother (2014) 0.87
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy. J Clin Microbiol (2006) 0.86
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
Vaccines against traveler's diarrhoea and rotavirus disease - a review. Wien Klin Wochenschr (2006) 0.81
A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants. J Infect Dis (2016) 0.80
Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. J Infect Dis (2016) 0.79
The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure. J Pediatric Infect Dis Soc (2013) 0.78
[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea]. Wien Med Wochenschr (2007) 0.78
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414. BMC Pediatr (2014) 0.75
The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. J Infect Dis (2016) 0.75
Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa. PLoS One (2014) 0.75
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol (1997) 7.45
Inactivation of poliovirus in digested sludge. Appl Environ Microbiol (1976) 6.23
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Identification of the virucidal agent in wastewater sludge. Appl Environ Microbiol (1977) 3.42
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst (2001) 3.02
M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol (2001) 2.81
Inactivation of enteric viruses in wastewater sludge through dewatering by evaporation. Appl Environ Microbiol (1977) 2.70
Heat inactivation of poliovirus in wastewater sludge. Appl Environ Microbiol (1976) 2.59
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus. J Virol (1975) 2.40
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1990) 2.37
Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr (1992) 2.31
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (1982) 2.11
Efficiency of human rotavirus propagation in cell culture. J Clin Microbiol (1984) 2.07
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis (1995) 2.05
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci U S A (1989) 2.05
Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J (2012) 2.02
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery (1988) 1.98
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res (1998) 1.97
Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation (1995) 1.93
35Cl NMR studies of zinc adenosine diphosphate complexes. Biochem Biophys Res Commun (1967) 1.92
Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science (1983) 1.82
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol (2000) 1.64
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Mechanism of poliovirus inactivation by ammonia. J Virol (1978) 1.64
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Colorectal cancer: a model for epigenetic tumorigenesis. Gut (2006) 1.62
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med (1989) 1.59
Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest (1995) 1.58
Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology (1995) 1.56
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Nature of the scrapie agent: evidence against a viroid. J Virol (1974) 1.48
Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47
Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology (2000) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol (1996) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing). J Virol (1986) 1.38
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36
Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods (1991) 1.35
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
Effects of moisture content on long-term survival and regrowth of bacteria in wastewater sludge. Appl Environ Microbiol (1981) 1.35
Enteric virus and indicator bacteria levels in a water treatment system modified to reduce trihalomethane production. Appl Environ Microbiol (1984) 1.35
Role of mycobactin in the growth and virulence of tubercle bacilli. Infect Immun (1974) 1.34
Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology (1994) 1.33
Hydrogen production by Anabaena cylindrica: effects of varying ammonium and ferric ions, pH, and light. Appl Environ Microbiol (1978) 1.33
Identification of detergents as components of wastewater sludge that modify the thermal stability of reovirus and enteroviruses. Appl Environ Microbiol (1978) 1.33
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization. Clin Chem (2000) 1.32
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol (2010) 1.31
Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J (1997) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
Mechanism of inactivation of enteric viruses in fresh water. Appl Environ Microbiol (1986) 1.27
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol (1992) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol (1984) 1.21
Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Topological analysis of the reovirus type 3 hemagglutinin. Virology (1983) 1.20
Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol (1985) 1.19
pH modification of the effects of detergents on the stability of enteric viruses. Appl Environ Microbiol (1979) 1.19
Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. Cancer Res (1997) 1.19
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest (1987) 1.18
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol (1994) 1.18
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Heat inactivation of enteric viruses in dewatered wastewater sludge. Appl Environ Microbiol (1978) 1.16
Comparison of VP4 and VP7 of five murine rotavirus strains. Virology (1994) 1.15
Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis (2000) 1.14
Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol (1997) 1.13
Discovery of an agent in wastewater sludge that reduces the heat required to inactivate reovirus. Appl Environ Microbiol (1977) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Comparison of methods for recovering indigenous viruses from raw wastewater sludge. Appl Environ Microbiol (1982) 1.13
Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer. J Clin Oncol (2005) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet (2009) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10